Alterity Therapeutics
(OTC) PRNAF
Alterity Therapeutics Financials at a Glance
Market Cap
$9.79M
Revenue (TTM)
$5.64M
Net Income (TTM)
$44.51M
EPS (TTM)
$-0.00
P/E Ratio
-0.90
Dividend
$0.00
Beta (Volatility)
1.19 (Average)
Dividend
$0.00
Beta (Volatility)
1.19 (Average)
Price
$0.00
Volume
10,000
Open
$0.00
Price
$0.00
Volume
10,000
Open
$0.00
Previous Close
$0.00
Daily Range
$0.00 - $0.00
52-Week Range
$0.00 - $0.01
Dividend
$0.00
Beta (Volatility)
1.19 (Average)
Price
$0.00
Volume
10,000
Open
$0.00
Previous Close
$0.00
Daily Range
$0.00 - $0.00
52-Week Range
$0.00 - $0.01
PRNAF News
PRNAF: Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Alterity Therapeutics
Industry
Biotechnology
Sector
Health CareEmployees
9
CEO
David A. Stamler, MD
Website
www.alteritytherapeutics.comHeadquarters
Melbourne, VIC 3000, AU
PRNAF Financials
Key Financial Metrics (TTM)
Gross Margin
97%
Operating Margin
-5%
Net Income Margin
-4%
Return on Equity
-46%
Return on Capital
-37%
Return on Assets
-26%
Earnings Yield
-1.11%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$9.79M
Shares Outstanding
10.88B
Volume
10.00K
Short Interest
0.00%
Avg. Volume
1.35K
Financials (TTM)
Gross Profit
$5.31M
Operating Income
$14.57M
EBITDA
$14.63M
Operating Cash Flow
$11.45M
Capital Expenditure
$0.00
Free Cash Flow
$11.45M
Cash & ST Invst.
$40.66M
Total Debt
$155.46K
Alterity Therapeutics Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonCurrently no data to display.
Earnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$0.00
-100.0%
Gross Profit
$57.87K
-103.2%
Gross Margin
0.00%
N/A
Market Cap
$9.79M
N/A
Market Cap/Employee
$978.79K
N/A
Employees
10
N/A
Net Income
$9.61M
-257.3%
EBITDA
$12.99M
-96.8%
Quarterly Fundamentals
Net Cash
$49.02M
+306.3%
Accounts Receivable
$6.84M
+17.8%
Inventory
$0.00
N/A
Long Term Debt
$130.87K
+71.1%
Short Term Debt
$32.97K
-81.6%
Return on Assets
-25.63%
N/A
Return on Invested Capital
-37.08%
N/A
Free Cash Flow
$0.00
+100.0%
Operating Cash Flow
$10.62M
-136.2%